✦ LIBER ✦

848 Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma (STS): A phase II trial

✍ Scribed by M.E. Blackstein; E.A. Eisenhauer; V. Bramwell; K. Belanger; S. Verma; S. Beare

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel as rescue medication in anthra

✍ W.J. Koestler; T. Brodowicz; Y. Attems; S. Tomek; M. Hejna; W.C.C. Fiebiger; G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Phase II Trial of Weekly Docetaxel/Gemci

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

A Phase II Trial of Docetaxel With Bevac

✍ Sara A. Hurvitz; Heather J. Allen; Rebecca L. Moroose; David Chan; Christopher H 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 598 KB

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Robert Mannel; Peter G. Rose 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A phase II study of tasisulam sodium (LY

✍ Christopher W. Ryan, Chacon Matias, Mark Agulnik, Antonio Lopez-Pousa, Charles W 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 155 KB

Doxorubicin alone versus intensified dox

✍ Judson, Ian; Verweij, Jaap; Gelderblom, Hans; Hartmann, Jörg T; Schöffski, Patri 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 320 KB